Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (81-90 of 392) with videos related to

Pageof 40
Sort By:
Blood|September 23, 2008
Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trialRob Pieters, Inge Appel, Hans-Juergen Kuehnel, et al.
International Journal of Cancer|March 13, 2024
Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004-2015: A comparative population-based studyHanne Peirelinck, Maya Schulpen, Raoull Hoogendijk, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 8, 2014
A novel 6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of a randomized clinical trialLidwien M Hanff, Ron A A Mathot, Oscar Smeets, et al.
Haematologica|September 13, 2005
Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemiaWim J E Tissing, Melchior Lauten, Jules P P Meijerink, et al.
The Lancet. Oncology|February 26, 2013
Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countriesKathy Pritchard-Jones, Rob Pieters, Gregory H Reaman, et al.
Genes, Chromosomes & Cancer|March 31, 2015
Response to the letter to the editor: 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk satisfaction in the SIOP2009/Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) trialKathy Pritchard-Jones, Richard Williams, Heidi Segers, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2016
Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemiaEmma M C Driessen, Sandra S Mimoso Pinhanços, Pauline Schneider, et al.
Haematologica|June 6, 2015
BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signaturesJudith M Boer, João R M Marchante, William E Evans, et al.
Digestive Diseases and Sciences|April 7, 2007
Alterations in epithelial and mesenchymal intestinal gene expression during doxorubicin-induced mucositis in miceBarbara A E de Koning, Dicky J Lindenbergh-Kortleve, Rob Pieters, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2020
Increasing incidence of cancer and stage migration towards advanced disease in children and young adolescents in the Netherlands, 1990-2017Ardine M J Reedijk, Leontien C Kremer, Otto Visser, et al.
Pageof 40

Showing results (81-90 of 392) with videos related to

Sort By:
Pageof 40
Blood|September 23, 2008
Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trialRob Pieters, Inge Appel, Hans-Juergen Kuehnel, et al.
International Journal of Cancer|March 13, 2024
Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004-2015: A comparative population-based studyHanne Peirelinck, Maya Schulpen, Raoull Hoogendijk, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 8, 2014
A novel 6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of a randomized clinical trialLidwien M Hanff, Ron A A Mathot, Oscar Smeets, et al.
Haematologica|September 13, 2005
Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemiaWim J E Tissing, Melchior Lauten, Jules P P Meijerink, et al.
The Lancet. Oncology|February 26, 2013
Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countriesKathy Pritchard-Jones, Rob Pieters, Gregory H Reaman, et al.
Genes, Chromosomes & Cancer|March 31, 2015
Response to the letter to the editor: 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk satisfaction in the SIOP2009/Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) trialKathy Pritchard-Jones, Richard Williams, Heidi Segers, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2016
Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemiaEmma M C Driessen, Sandra S Mimoso Pinhanços, Pauline Schneider, et al.
Haematologica|June 6, 2015
BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signaturesJudith M Boer, João R M Marchante, William E Evans, et al.
Digestive Diseases and Sciences|April 7, 2007
Alterations in epithelial and mesenchymal intestinal gene expression during doxorubicin-induced mucositis in miceBarbara A E de Koning, Dicky J Lindenbergh-Kortleve, Rob Pieters, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2020
Increasing incidence of cancer and stage migration towards advanced disease in children and young adolescents in the Netherlands, 1990-2017Ardine M J Reedijk, Leontien C Kremer, Otto Visser, et al.
Pageof 40